Omvardnad Sehepa Sweden AB
ActiveKey figures
Key figures
2024Summary: Omvardnad Sehepa Sweden AB
What kind of company is it?
Omvardnad Sehepa Sweden AB (org. no. 559367-3006) is a limited company (AB). The company was registered in 2022 and has existed for 4 years. Registered seat: Kista. Industry according to Statistics Sweden: specialised hospital somatic activities (SNI 86102).
How is the company doing financially?
Net sales in financial year 2024 were 169 000 kr, down 79,0 % on the previous year (806 000 kr). From 2022 to 2024, net sales declined by an average of 50,4 % per year. Financial year 2024 ended with a loss of 13 760 kr. The company was profitable in 1 of the 3 reported financial years. Employees in financial year 2023: 1. Net sales per employee were 806 000 kr.
What should you look out for?
Equity was negative at the end of financial year 2024 (−110 352 kr). Equity is below half of the share capital (27 000 kr); under the Swedish Companies Act the board may then need to prepare a balance sheet for liquidation purposes (kontrollbalansräkning).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2022–2024
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Sales revenue | 687 000 | 806 000 | 169 000 |
| Profit for the reporting year | 20 381 | −143 973 | −13 760 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 231 814 | 102 375 | 7 899 |
| Total liabilities | 184 433 | 198 967 | 118 251 |
| Total equity | 47 381 | −96 592 | −110 352 |
| Employees | 1 | 1 | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.